Aptamer-functionalized quercetin thermosensitive liposomes for targeting drug delivery and antitumor therapy
- 9 September 2022
- journal article
- research article
- Published by IOP Publishing in Biomedical Materials
- Vol. 17 (6) , 065003
Abstract
Chemo-thermotherapy, as a promising cancer combination therapy strategy, has attracted widespread attention. In this study, a novel aptamer functionalized thermosensitive liposome encapsulating hydrophobic drug quercetin was fabricated as an efficient drug delivery system. This aptamer-functionalized quercetin thermosensitive liposomes (AQTSL) combined the merits of high-loading yield, sustained drug release, long-term circulation in the body of PEGylated liposomes, passive targeting provided by 100–200 nm nanoparticles, active targeting and improved internalization effects offered by AS1411 aptamer, and temperature-responsive of quercetin release. In addition, AQTSL tail vein injection combined with 42 °C water bath heating on tumor site (AQTSL + 42 °C)treatment inhibited the tumor growth significantly compared with the normal saline administration ( p < 0.01), and the inhibition rate reached 75%. Furthermore, AQTSL + 42 °C treatment also slowed down the tumor growth significantly compared with QTSL combined with 42 °C administration ( p < 0.05), confirming that AS1411 decoration on QTSL increased the active targeting and internalization effects of the drug delivery system, and AS1411 aptamer itself might also contribute to the tumor inhibition. These data indicate that AQTSL is a potential carrier candidate for different hydrophobic drugs and tumor targeting delivery, and this kind of targeted drug delivery system combined with temperature responsive drug release mode is expected to achieve an ideal tumor therapy effect.Keywords
Funding Information
- Natural Science Foundation of Hebei Province (C2019203556)
- Hebei Provincial Department of Science and Technology (19272401D)
- National Natural Science Foundation of China (62071413)
- Education Department of Hebei Province (ZD2020147)
This publication has 39 references indexed in Scilit:
- Direct Observation of Nanoparticle–Cancer Cell Nucleus InteractionsACS Nano, 2012
- Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacyInternational Journal of Nanomedicine, 2011
- Targeting Therapy with Mitosomal Daunorubicin plus Amlodipine Has the Potential To Circumvent Intrinsic Resistant Breast CancerMolecular Pharmaceutics, 2010
- Stimuli-responsive controlled-release system using quadruplex DNA-capped silica nanocontainersNucleic Acids Research, 2010
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre studyThe Lancet Oncology, 2010
- Targeted temperature sensitive magnetic liposomes for thermo-chemotherapyJournal of Controlled Release, 2010
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer CellsCancer Research, 2008
- AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolinMolecular Cancer Therapeutics, 2006
- Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapyJournal of Neuroimmunology, 2006
- Thalidomide. A New BeginningCancer Practice, 2000